YAMAMARU Co.,Ltd.
FDA import alert and refusal historyShizuoka, JapanFEI 3004877406
As of October 26, 2026, YAMAMARU Co.,Ltd. (Shizuoka, Japan) is on the red list of FDA Import Alert 16-74 (Uneviscerated salt-cured, dried, smoked or fermented fish) for wild baby anchovy, published by FDA on June 22, 2012, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-74 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for YAMAMARU Co.,Ltd.
1 record, newest first. Each line links to the FDA page it came from.
2012
- Import alert listingListed on Import Alert 16-74red listWild Baby AnchovySource
Questions about YAMAMARU Co.,Ltd.
- Is YAMAMARU Co.,Ltd. on an FDA import alert?
- Yes. As of October 26, 2026, YAMAMARU Co.,Ltd. is on the red list of FDA Import Alert 16-74, “Uneviscerated salt-cured, dried, smoked or fermented fish”, for wild baby anchovy; FDA published the listing on June 22, 2012.
- Has FDA refused shipments from YAMAMARU Co.,Ltd.?
- No FDA import refusals for YAMAMARU Co.,Ltd. appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is YAMAMARU Co.,Ltd.'s FEI number?
- YAMAMARU Co.,Ltd.'s FDA Establishment Identifier (FEI) is 3004877406.
- Can shipments from YAMAMARU Co.,Ltd. still enter the U.S.?
- Shipments of wild baby anchovy from YAMAMARU Co.,Ltd. can be detained without physical examination under Import Alert 16-74; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from YAMAMARU Co.,Ltd.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.